Iovance Biotherapeutics
Price & Volume
Stats
See moreOpen | $3.68 |
Previous Close | $3.64 |
Day Range | $3.53-$3.70 |
52W Range | $1.64-$5.63 |
Market Cap | $1.4B |
Shares Short | 110M |
Financials
See moreRevenue (12 Mos) | $263.5M |
Revenue Growth (YoY) | 17.7% |
Gross Profit (12 Mos) | $90.3M |
Diluted EPS | -$1.09 |
News
See moreYahoo Finance • 9 days ago
Neurocrine Biosciences Details $2.9B Soleno Buyout, Touts Vykat XR as Potential Blockbuster
Yahoo Finance • last month
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine
Yahoo Finance • last month
UBS Raises PT on Iovance Biotherapeutics (IOVA)
Yahoo Finance • 2 months ago
Iovance Biotherapeutics GAAP EPS of -$0.18 in-line, revenue of $86.71M beats by $5.7M
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 975 |
